BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1698716)

  • 1. Effects of gliotoxin on Langerhans' cell function: contact hypersensitivity responses and skin graft survival.
    McMinn PC; Halliday GM; Muller HK
    Immunology; 1990 Sep; 71(1):46-51. PubMed ID: 1698716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced survival of skin grafts depleted of Langerhans' cells by treatment with dimethylbenzanthracene.
    Odling KA; Halliday GM; Muller HK
    Immunology; 1987 Nov; 62(3):379-85. PubMed ID: 3117676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptance of class II major histocompatibility complex disparate skin grafts associated with suppressor cells and elevated Langerhans cell numbers.
    Odling KA; Halliday GM; Muller HK
    Pathology; 1992 Jul; 24(3):184-9. PubMed ID: 1437291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
    Halliday GM; Odling KA; Muller HK
    Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class II expression by Langerhans' cells and lymph node dendritic cells: possible evidence for maturation of Langerhans' cells following contact sensitization.
    Cumberbatch M; Gould SJ; Peters SW; Kimber I
    Immunology; 1991 Nov; 74(3):414-9. PubMed ID: 1769690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
    Rosenberg AS; Katz SI; Singer A
    J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T; Holda JH; Claman HN
    J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. VI. Detection of a non-MHC gene(s) in the E alpha-bearing RIIIS mouse strain that is associated with a specific lack of T cell responses to the M. arthritidis soluble mitogen.
    Cole BC; Tuller JW; Sullivan GJ
    J Immunol; 1987 Aug; 139(3):927-35. PubMed ID: 3110289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity.
    Grabbe S; Steinbrink K; Steinert M; Luger TA; Schwarz T
    J Immunol; 1995 Nov; 155(9):4207-17. PubMed ID: 7594576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice.
    Isakov N; Bach FH
    J Immunol; 1984 Jan; 132(1):50-6. PubMed ID: 6418804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptides of a major histocompatibility complex class I (Kb) molecule cause prolongation of skin graft survival and induce specific down-regulatory T cells demonstrable in the mixed lymphocyte reaction.
    Brondz BD; Kazansky DB; Chernyshova AD; Ivanov VS
    Immunology; 1995 Oct; 86(2):219-23. PubMed ID: 7490121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance induction to multiple minor histoincompatible cells by activated B cells is associated with preferential activation of Th2 cells.
    Gorczynski RM; Kiziroglu F
    Transplantation; 1994 Jul; 58(1):51-8. PubMed ID: 8036708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Langerhans cells that migrate to skin after intravenous infusion regulate the induction of contact hypersensitivity.
    Cruz PD; Tigelaar RE; Bergstresser PR
    J Immunol; 1990 Apr; 144(7):2486-92. PubMed ID: 1969448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens.
    Williams IR; Perry LL
    J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG; Liu Z; Wu Y
    Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor T cell circuits in contact sensitivity. II. Induction and characterization of an efferent-acting, antigen-specific, H-2-restricted, monoclonal T cell hybrid-derived suppressor factor specific for DNFB contact hypersensitivity.
    Miller SD
    J Immunol; 1984 Dec; 133(6):3112-20. PubMed ID: 6208271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Migration of human antigen-presenting cells in a human skin graft onto nude mice model after contact sensitization.
    Hoefakker S; Balk HP; Boersma WJ; van Joost T; Notten WR; Claassen E
    Immunology; 1995 Oct; 86(2):296-303. PubMed ID: 7490132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.